Notice: Prescription Drug List (PDL): Fluticasone propionate
The purpose of this Notice of Amendment is to notify that Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt certain uses of Fluticasone propionate.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Fluticasone propionateHTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Fluticasone propionateHTMLFrench publication HTML
Similar records